ACLARION, INC. Accounts Payable
ACLARION, INC. (ACON) had Accounts Payable of $704.98 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $704.98K.
- 2026-03-31: Accounts Payable, Current $587.29K.
- 2025-12-31: Accounts Payable, Current $332.96K.
- 2025-09-30: Accounts Payable, Current $274.36K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $704.98K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $587.29K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $332.96K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $274.36K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $281.52K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $516.27K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $531.60K 10-K · filed 2026-03-18 |
| 2024-09-30 | $331.76K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $179.12K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $195.71K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $760.53K 10-K · filed 2025-04-09 |
| 2023-09-30 | $686.20K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $607.62K 10-Q · filed 2023-08-25 |
| 2023-03-31 | $544.74K 10-Q · filed 2023-07-03 |
| 2022-12-31 | $462.20K 10-K · filed 2024-03-28 |
| 2022-09-30 | $718.28K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.18M 10-Q · filed 2022-08-15 |
| 2021-12-31 | $1.07M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |